Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Foster Adds Manufacturing Line | Contract Pharma

What are you searching for?

Sign in
Breaking News

Foster Adds Manufacturing Line

Expands extrusion compounding capacity for custom pre-colored polymers

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Foster Corp. has added extrusion compounding capacity for custom pre-colored polymers used in Class I medical applications. The new line is designed to optimize pigment dispersion of challenging colors and polymers, and maximize throughput necessary to reduce compounding costs.
 
The new manufacturing line includes twin-screw extrusion capable of volume output in excess of 1,000 lbs/hour (454 kg/hour). The equipment was designed to serve high volume medical applications where color is critical and cost is important, such as custom colored polymers for bandage or packaging film.
 
“As a leader in polymer compounding for minimally invasive devices and catheters, Foster has developed an expertise in the dispersion of additives in polymers for thin wall parts,” said Christine Howe, director of manufacturing at Foster Corp. “We have designed this new larger line to provide the same quality and consistency for Class I devices with demanding color requirements. These applications generally consume higher volumes and are under increased pressure to reduce costs.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters